NCT00139347 - Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants | Biotech Hunter

Enrollment

6,360

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL

2-dose oral live attenuated G1P[8] human rotavirus vaccine

Trial Locations (17)

GSK Investigational Site, Bogotá

GSK Investigational Site, La Plata

GSK Investigational Site, Córdoba

GSK Investigational Site, Córdoba

GSK Investigational Site, Mendoza

GSK Investigational Site, Villanueva

GSK Investigational Site, Tunuyán

GSK Investigational Site, Río Cuarto

GSK Investigational Site, Colonia Caroya

GSK Investigational Site, Porto Alegre

GSK Investigational Site, Cali Colombia

GSK Investigational Site, Santiago de Cali

GSK Investigational Site, Santo Domingo, Distrito Nacional

GSK Investigational Site, Santo Domingo

GSK Investigational Site, Comayagüela

GSK Investigational Site, Panama City

GSK Investigational Site, David